Article

Femtosecond laser cleared for lens fragmentation

The FDA has granted 510(k) clearance to a femtosecond laser (LenSx, LenSx Lasers Inc.) for use in cataract surgery. Specifically, the device is used for laser phacofragmentation.

Aliso Viejo, CA

-The FDA has granted 510(k) clearance to a femtosecond laser (LenSx, LenSx Lasers Inc.) for use in cataract surgery. Specifically, the device is used for laser phacofragmentation.

“The . . . phacofragmentation clearance is an important milestone in delivering the benefits of laser refractive cataract surgery to patients, including the reduced use of ultrasonic power to fragment and remove the cataractous lens,” said Stephen G. Slade, MD, of Houston, who performed the initial series of procedures with the laser in the United States.

Laser phacofragmentation with this laser resulted in a 43% reduction in average phaco power and a 51% reduction in effective phaco time, according to a study published in the

Journal of Refractive Surgery.

Additional reported benefits of the technology included the ability to deliver a perfectly centered and sized capsulotomy, resulting in more reproducible positioning of the replacement IOL and in the potential for reduced dependence on eyeglasses, said LenSx in a prepared statement.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.